Key result
The PNPLA3 rs738409 variant was associated with an increased risk of NAFLD in Indonesian patients, whereas the ADIPOQ rs2241767 variant showed no significant association.
Why the study?
Despite the increasing prevalence of NAFLD, studies assessing the association between PNPLA3 and ADIPOQ gene variants and NAFLD in the Indonesian population were limited.
Are PNPLA3 rs738409 and ADIPOQ rs2241767 gene variants associated with NAFLD incidence and severity in an Indonesian population?
Case-Control (n=152)
No
Are PNPLA3 rs738409 and ADIPOQ rs2241767 gene variants associated with NAFLD incidence and severity in an Indonesian population?
The PNPLA3 rs738409 variant is significantly associated with NAFLD incidence in the Indonesian population, highlighting a genetic susceptibility factor.
Answers are grounded in this paper and cite their sources.
PNPLA3 variant may aid ethnic NAFLD risk assessment in Indonesians; leaves open prospective validation before clinical adoption.
BackgroundVariants of adiponutrin (PNPLA3) and adiponectin (ADIPOQ) genes were considered to be associated with non-alcoholic fatty liver disease (NAFLD). Although the prevalence of NAFLD is increasing, there are limited numbers of studies about the association in Indonesian population.ObjectiveTo confirm whether specific variants of adiponutrin (PNPLA3) and adiponectin (ADIPOQ) genes are associated with NAFLD in Indonesian patients.MethodsData and DNA of 152 participants were obtained from a previous study in Dr. Kariadi Hospital, Semarang, Indonesia. PCR-RFLP analysis was performed for detection of PNPLA3 rs738409 and ADIPOQ rs2241767 variants. The diagnosis and severity of NAFLD were assessed according to NAFLD activity score (NAS) based on histopathology assessment of liverbiopsy.ResultsAllele G of PNPLA3rs738409 was associated with NAFLD in both bivariate (p=0.009, OR 2.52, CI 95% 1.25–5.07) and multivariate (p=0.008, OR 2.62, CI 95% 1.29%–5.32%) analysis, while ADIPOQ rs2241767 had no significant association. In NAFLD participants, both genotypes showed allele G was higher in the group of possible non-alcoholic steatohepatitis (NASH) – NASH (NAS >2) than in the simple steatosis group (NAS <2) i.e. 40.0% vs. 3.75% for the rs2241767 variant and 23.75% vs. 1.25% for the rs738409 variant, without significant association.ConclusionVariant PNPLA3 rs738409 was associated with NAFLD incidence in studied population. Among NAFLD participants, the frequency of both variants were found higher in the possible NASH – NASH group, yet needs to be confirmed with more participants and a multicenter study.Data and DNA of 152 participants were obtained from a previous study in Dr. Kariadi Hospital, Semarang, Indonesia. PCR-RFLP analysis was performed for detection of PNPLA3 rs738409 and ADIPOQ rs2241767 variants. The diagnosis and severity of NAFLD were assessed according to NAFLD activity score (NAS) based on histopathology assessment of liverbiopsy.
No takes yet. Share an insight, caveat, or question.
Meagratia et al. (2021) conducted a case-control in Non-Alcoholic Fatty Liver Disease (NAFLD) (n=152). PNPLA3 rs738409 and ADIPOQ rs2241767 variants vs. Controls without NAFLD was evaluated on Association of PNPLA3 rs738409 allele G with NAFLD (multivariate analysis) (OR 2.62, 95% CI 1.29-5.32, p=0.008). The PNPLA3 rs738409 variant was associated with an increased risk of NAFLD in Indonesian patients, whereas the ADIPOQ rs2241767 variant showed no significant association.
Synapse has enriched 10 related papers. Consider them for comparative context: